Join us as we sit down with Dr. Deborah Stephens from the University of Utah, as we discover the latest breakthroughs in treating chronic lymphocytic leukemia (CLL).  We also gain valuable insights into enhancing patient’s quality of life

In this episode, Dr. Stephens emphasizes the importance of effective communication with your healthcare team, unveiling strategies that not only optimize disease management, but also minimize the impact of side effects. Your path to empowered long-term care with CLL begins here.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by: AbbVie Inc.; BeiGene USA, Inc.; Genentech, Inc. & Biogen.

Delve into the complex landscape of non-Hodgkin lymphoma research, where a cure is pursued amidst a backdrop of over 100 subtypes of this disease.

In this episode, Dr. Kieron Dunleavy, of MedStar Georgetown University Hospital, breaks down the differences in treatments, prognosis and goals for both slow-growing and aggressive subtypes of non-Hodgkin lymphoma. Discover the remarkable momentum of scientific progress that increased the understanding and management of lymphoma, igniting a renewed sense of hope for patients and their loved ones.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by: Eli Lilly and Company and Genentech, Inc. & Biogen.

While chronic myelomonocytic leukemia (CMML) is a rare disease, it is not rare to the patients and loved ones who are affected by it.

In this episode, Dr. Mrinal Patnaik of the Mayo Clinic in Rochester, MN, discusses the unique aspects of CMML and how it is classified and treated.  Dr. Patnaik shares the latest treatment advances and discusses the importance of patients’ quality of life.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by: Taiho Oncology, Inc.

Myeloproliferative Neoplasms (MPNS) is an umbrella term that includes myelofibrosis (MF), essential thrombocythemia (ET) and polycythemia vera (PV). In this episode, Dr. Angela Fleischman of the Chao Comprehensive Cancer Center in Orange, CA, delves into these disorders in more detail. She shares how a patient’s quality of life can be improved with the latest advancements in treatment.  

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by: Bristol Myers Squibb.

Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial Healthcare System in Pembroke Pines, Florida. In this episode, we explore the latest advances and what the future holds for CAR T-cell therapy.   

This comprehensive view of CAR T-cell therapy will give blood cancer patients and their families hope. Through the utilization of targeted therapies, we can now see a future filled with better outcomes and potential cures.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this program is provided by: Allogene Therapeutics; Bristol Myers Squibb; CRISPR Therapeutics Ltd; Janssen Oncology & Legend Biotech; Kite, A Gilead Company and Novartis Pharmaceuticals Corp.

Join us as we speak to Dr. Richard Larson and Dr. Anand Patel from University of Chicago Medicine about chronic myeloid leukemia (CML). In this episode, they discuss the latest advances in treatment for CML and what is on the horizon.

With decades of progress with targeted treatments, CML patients are now given more hope of achieving deep remission and potentially discontinuing medication. A cure for an incurable disease may now be in sight.

Mentioned on this episode: 

• Chronic Myeloid Leukemia (CML)
• Tyrosine Kinase Inhibitors (TKIs)
• FISH test
• Stem Cell Transplant
• Cellular Therapies
• Instilling Hope Through Progress: Myelodysplastic Syndromes (MDS)

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Young Adult Resources
• Survivorship Workbook
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations

Support for this episode is provided by University of Chicago Comprehensive Cancer Center.

Join us as we speak to Laurie Adami, a follicular lymphoma (non-Hodgkin lymphoma) survivor. In this episode, Laurie shares her long journey through multiple cancer treatments, which eventually led to CAR T-cell therapy and complete remission.

Hear one patient’s story of hope, as new treatments continued to come out, keeping her stable until the one that finally worked was approved for her disease. Her story of resilience and determination to stay alive for her young son is the inspiration that so many blood cancer patients need.

Mentioned on this episode: 

• Follicular Lymphoma
• CAR T-cell Therapy
• Sjorgren’s Syndrome
• Patti Robinson Kaufmann First Connection Program
• Allogeneic Stem Cell Transplant
• Graft-Vs-Host Disease (GVHD)
• LLS Public Policy & Advocacy
• Light The Night
• Woman of The Year (Visionaries of the Year)
• Student of The Year
• Team In Training

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Free booklets 
• Clinical Trial Support Center
• LLS Community 
• Online chats 
• Support groups 
• Caregiver support 
• Caregiver Workbook
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by: Allogene Therapeutics; Bristol Myers Squibb; CRISPR Therapeutics; Janssen Oncology & Legend Biotech; Kite, A Gilead Company; Novartis Oncology.

Join us as we speak to Dr. Anand Patel and Dr. Satyajit Kosuri from The University of Chicago Medicine about the latest treatment advances for myelodysplastic syndromes (MDS). In honor of MDS Awareness Day on October 25th, the doctors discuss how MDS develops, why genetic mutations matter when choosing a treatment course, and how stem cell transplantation, targeted treatments and cellular therapies bring hope to MDS patients and their families.

Mentioned on this episode: 

• Myelodysplastic syndromes
• Acute Myeloid Leukemia
• Transplant Support and Graft-Versus-Host-Disease (GVHD) episode
• Patient-Doctor Perspectives: Hereditary Myelodysplastic Syndromes (MDS)
• Transplant Optimization Program (TOP)
• MyeloMATCH initiative
• CAR T-cell Therapy
• Stem Cell Transplant
• Cellular Therapies
• Graft-Vs-Host Disease
• Be The Match – Bone Marrow Donor Registry

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Young Adult Resources
• Survivorship Workbook
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations

Support for this episode is provided by University of Chicago Medicine.

Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses current treatments for chronic lymphocytic leukemia (CLL) and the exciting possibilities for the future using immunotherapies.

Dr. Davids shares how the goal of treatment is long term remission and quality of life. Since 2010, BTK Inhibitors, CAR T-cell therapy and other treatments have come on the market and have increased the possibilities for patients to live a long life with CLL.

Mentioned on this episode: 

• Chronic Lymphocyctic Leukemia (CLL)
• How CAR T Cell Therapy Gives Hope to Cancer Patients Podcast Episode
• CURE Magazine Article on CAR T and Young CLL Patients
• American Journal of Managed Care – CAR T cells persist
• Minimal/Measurable Residual Disease (MRD) Fact Sheet
• CAR T-cell Therapy
• CAR T-Cell Therapy Webinar
• How CAR T-Cell Therapy Works In Augmented Reality
• Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Autologous Stem Cell Transplant
• LLS COVID-19 Resources
• Clinical Trial Support Center
• The Bloodline Subscriber Lounge

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by BeiGene USA, Inc.; Bristol Myers Squibb; Genentech, Inc. & Biogen; Loxo Oncology at Lilly and Pharmacyclics, An AbbVie Company & Janssen Biotech, and Thomas D. Oxley Fund for CLL Patient Education and Support.

Please join us as we speak to Dr. Shernan Holtan and guest co-host from LLS, Christina Neilsen. In this episode, Dr. Holtan discusses stem cell transplants; how they work, the different types of transplants, and the side effects, including graft-vs-host disease (GVHD).

Dr. Holtan shares exciting new research on reducing GVHD and provides blood cancer patients with hope as transplantations continue to improve and bring about potential cures.

Mentioned on this episode: 

• Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Autologous Stem Cell Transplant
• Graft-verses-Host Disease Fact Sheet
• CAR T-cell Therapy
• Clinical Trial Support Center
• Hope Lodge
• Posttransplant Cyclophosphamide
• Be The Match

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook